Running or cycling may lower your chance of prostate cancer.

0
85

Running or cycling may lower your chance of prostate cancer. According to a recent study, men who engage in more cycling, jogging, and swimming in their routines have a lower risk of prostate cancer.

It was shown that men who increased their level of fitness by 3% over the course of a year had a 35% lower risk of developing prostate cancer than those whose fitness decreased.

Scientists advised men to improve their cardiorespiratory fitness, stressing that achieving a moderate level of fitness is essential for preventing prostate cancer.Running or cycling may lower your chance of prostate cancer.

For a better weekly routine, co-author Dr. Kate Bolam recommended males to select pleasurable activities that raise heart rate.

“The Swedish School of Sport and Health Sciences in Stockholm’s Dr. Kate Bolam, who co-authored the study, stated that the requirement for duration and frequency decreases with increasing intensity of activity.”

“The trick is to regularly challenge your cardiovascular system so that it improves to match the requirements placed on it,” she continued. If you enjoy it and it raises your heart rate, you could even try line dancing.”

The study, carried out by the Swedish School of Sport and Health Sciences, examined data from 57,652 men and was published in the British Journal of Sports Medicine on January 30.

Every participant’s height, BMI, lifestyle, physical activity levels, and perception of health were closely examined in addition to their annual cardiorespiratory fitness tests.

During the course of a seven-year follow-up, 592 men received a prostate cancer diagnosis, and 46 of them passed away.

Although their chance of dying stayed the same, those whose fitness rose by 3% a year were shown to be 35% less likely to get prostate cancer.

This study challenges earlier results that suggested men with higher cardiovascular fitness may be somewhat more at risk for prostate cancer. It is the first to firmly correlate exercise to a lower risk of prostate cancer.